|
1
|
Jue TR and McDonald KL: The challenges
associated with molecular targeted therapies for glioblastoma. J
Neurooncol. 127:427–434. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Koukourakis MI, Mitrakas AG and
Giatromanolaki A: Therapeutic interactions of autophagy with
radiation and temozolomide in glioblastoma: Evidence and issues to
resolve. Br J Cancer. 114:485–496. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dinkova-Kostova AT and Kostov RV:
Glucosinolates and isothiocyanates in health and disease. Trends
Mol Med. 18:337–347. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Singh SV and Singh K: Cancer
chemoprevention with dietary isothiocyanates mature for clinical
translational research. Carcinogenesis. 33:1833–1842. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Trachootham D, Zhou Y, Zhang H, Demizu Y,
Chen Z, Pelicano H, Chiao PJ, Achanta G, Arlinghaus RB, Liu J and
Huang P: Selective killing of oncogenically transformed cells
through a ROS-mediated mechanism by beta-phenylethyl
isothiocyanate. Cancer Cell. 10:241–252. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Grzywa R, Winiarski Ł, Psurski M, Rudnicka
A, Wietrzyk J, Gajda T and Oleksyszyn J: Synthesis and biological
activity of diisothiocyanate-derived mercapturic acids. Bioorg Med
Chem Lett. 26:667–671. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Schneider M, Ströbele S, Nonnenmacher L,
Siegelin MD, Tepper M, Stroh S, Hasslacher S, Enzenmüller S,
Strauss G, Baumann B, et al: A paired comparison between
glioblastoma ‘stem cells’ and differentiated cells. Int J Cancer.
138:1709–1718. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ströbele S, Schneider M, Schneele L,
Siegelin MD, Nonnenmacher L, Zhou S, Karpel-Massler G, Westhoff MA,
Halatsch ME and Debatin KM: A potential role for the inhibition of
PI3K signaling in glioblastoma therapy. PLoS One. 10:e01316702015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Westhoff MA, Zhou S, Bachem MG, Debatin KM
and Fulda S: Identification of a novel switch in the dominant forms
of cell adhesion-mediated drug resistance in glioblastoma cells.
Oncogene. 27:5169–5181. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cheng F, Li W, Zhou Y, Shen J, Wu Z, Liu
G, Lee PW and Tang Y: admetSAR: A comprehensive source and free
tool for evaluating chemical ADMET properties. J Chem Inf Model.
52:3099–3105. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Schneider M, Ströbele S, Nonnenmacher L,
Siegelin MD, Tepper M, Stroh S, Hasslacher S, Enzenmüller S,
Strauss G, Baumann B, et al: A paired comparison between
glioblastoma ‘stem cells’ and differentiated cells. Int J Cancer.
138:1709–1718. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Singh SK, Clarke ID, Terasaki M, Bonn VE,
Hawkins C, Squire J and Dirks PB: Identification of a cancer stem
cell in human brain tumors. Cancer Res. 63:5821–5828.
2003.PubMed/NCBI
|
|
13
|
Liu G, Yuan X, Zeng Z, Tunici P, Ng H,
Abdulkadir IR, Lu L, Irvin D, Black KL and Yu JS: Analysis of gene
expression and chemoresistance of CD133+ cancer stem
cells in glioblastoma. Mol Cancer. 5:672006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jordan CT, Guzman ML and Noble M: Cancer
stem cells. N Engl J Med. 355:1253–1261. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jadhav U, Ezhilarasan R, Vaughn SF, Berhow
MA and Mohanam S: Dietary isothiocyanate iberin inhibits growth and
induces apoptosis in human glioblastoma cells. J Pharmacol Sci.
103:247–251. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhu Y, Liu A, Zhang X, Qi L, Zhang L, Xue
J, Liu Y and Yang P: The effect of benzyl isothiocyanate and its
computer-aided design derivants targeting alkylglycerone phosphate
synthase on the inhibition of human glioma U87MG cell line. Tumour
Biol. 36:3499–3509. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tang NY, Chueh FS, Yu CC, Liao CL, Lin JJ,
Hsia TC, Wu KC, Liu HC, Lu KW and Chung JG: Benzyl isothiocyanate
alters the gene expression with cell cycle regulation and cell
death in human brain glioblastoma GBM 8401 cells. Oncol Rep.
35:2089–2096. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shang HS, Shih YL, Lu TJ, Lee CH, Hsueh
SC, Chou YC, Lu HF, Liao NC and Chung JG: Benzyl isothiocyanate
(BITC) induces apoptosis of GBM 8401 human brain glioblastoma
multiforms cells via activation of caspase-8/bid and the reactive
oxygen species-dependent mitochondrial pathway. Environmental
Toxicology. 31:1751–1760. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chou YC, Chang MY, Wang MJ, Harnod T, Hung
CH, Lee HT, Shen CC and Chung JG: PEITC induces apoptosis of human
brain glioblastoma GBM8401 cells through the extrinsic- and
intrinsic -signaling pathways. Neurochem Int. 81:32–40. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Portnow J, Badie B, Chen M, Liu A,
Blanchard S and Synold TW: The neuropharmacokinetics of
temozolomide in patients with resectable brain tumors: Potential
implications for the current approach to chemoradiation. Clin
Cancer Res. 15:7092–7098. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Patel MA, Kim JE, Ruzevick J, Li G and Lim
M: The future of glioblastoma therapy: Synergism of standard of
care and immunotherapy. Cancers (Basel). 6:1953–1985. 2014.
View Article : Google Scholar : PubMed/NCBI
|
